CWBR cheap anti-aging stock

٢ أبريل ٢٠٢٢

CWBR CohBar is a clinical stage biotechnology company which develops mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases.

CWBR closed few months ago a $15.0 Million Offering of Common Stock and Warrants at $0.72, so this is a safe upside in my opinion if you want to enter now.

Cantor Fitzgerald brokerage has a $2.5 price target for it.

٢٥ مايو ٢٠٢٣

تم فتح الصفقة

CWBR Agrees To Merge With Morphogenesis To Advance Late-Stage Oncology Candidates